Bambuterol Hydrochloride

盐酸班布特罗

Report date: 2022/06/29 15:42:54
NME

Base Information

Drug NameBambuterol Hydrochloride
Drug Alias NameBambuterolum Hydrochloride盐酸班部特罗班布特罗盐酸盐BambecKWD-2183
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructiveBronchial SpasmAsthma +[4] 
Global Approved IndicationsPulmonary Disease, Chronic ObstructiveBronchial SpasmAsthma
Approved Indications in ChinaPulmonary Disease, Chronic ObstructiveAsthma
Original Approved Country/TerritoryUnited Kingdom
Original Approved Date1992/08/04
Country/TerritoryUnited KingdomMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesDongguan Kaifa Biological Medicine Co LtdAstrazeneca Pharmaceutical Co LtdAstrazeneca Uk Ltd +[4] 
Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructiveBronchial SpasmAsthma +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeR03CC12
Related LinksWikipediaDrugBankKEGG